MedTrace Logo

Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD

NCT04494360 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 830

Last updated 2025-03-30

No results posted yet for this study

Summary

The purpose of this study is to estimate the prevalence of genetic variants associated with liver disease in participants who are known, or are likely to have NAFLD.

Conditions

  • Healthy

Interventions

OTHER

No intervention

No investigational medicinal product will be administered as a part of this study.

Sponsors & Collaborators

  • Janssen Research & Development, LLC

    lead INDUSTRY

Principal Investigators

  • Janssen Research & Development, LLC Clinical Trial · Janssen Research & Development, LLC

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-07
Primary Completion
2022-10-10
Completion
2022-10-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04494360 on ClinicalTrials.gov